Prostaglandin Receptor Inhibitors

TXA₂/TP

TXB₂

Prostaglandin Receptor Inhibitors, Agonists, Antagonists, Activators & Modulators

Product Name	DP	EP	FP	IP	TXA₂/TP	TXB₂	Purity
Prostaglandin E2		EP					99.76%
Prostaglandin E1		EP					98.81%
U-46619					TXA₂/TP		≥99.0%
Tranilast	DP2, IC₅₀: 0.1 mM						99.57%
Prostaglandin D2	DP						99.45%
Dinoprost			FP Receptor				99.63%
PF-04418948		EP2, IC₅₀: 16 nM					99.25%
ONO-AE3-208		EP4, Ki: 1.3 nM EP3, Ki: 30 nM	FP, Ki: 790 nM		TP Receptor, Ki: 2400 nM		98.65%
Latanoprost			FP Receptor				99.85%
Selexipag				hIP, Ki: 260 nM			99.92%
Treprostinil			FP Receptor, Ki: 4680 nM	IP Receptor, EC₅₀: 1.9 nM IP Receptor, Ki: 32.1 nM	TP Receptor, EC₅₀: 919 nM		99.98%
Iloprost				IP			99.76%
16,16-Dimethyl prostaglandin E2		EP2 EP4					≥98.0%
DG-041		EP3, IC₅₀: 4.6-8.1 nM					≥99.0%
L-798106		EP3, IC₅₀: 0.3 nM EP4, IC₅₀: 916 nM EP1, IC₅₀: >5000 nM EP2, IC₅₀: >5000 nM					99.81%
Asapiprant	DP1, Ki: 0.44 nM						99.53%
Laropiprant	DP, Ki: 0.57 nM				TP Receptor, Ki: 2.95 nM		99.93%
Grapiprant		dog EP4, IC₅₀: 35 nM dog EP4, Ki: 24 nM					99.57%
GW627368		EP					99.81%
Cefminox sodium				IP Receptor			99.83%
RO1138452				Rat I₂ Receptor, IC₅₀: 7 nM Rat I₂ Receptor, pKi: 8.33			≥98.0%
Fevipiprant	DP2, Kd: 1.14 nM						99.51%
Travoprost			FP				99.99%
Omidenepag		hEP4, IC₅₀: 5480 nM hEP2, IC₅₀: 10 nM hEP2, EC₅₀: 1.1 nM					99.67%
Ramatroban	hDP2, IC₅₀: 113 nM hDP2, IC₅₀: 33.4 μM				hTP, IC₅₀: 14 nM		99.10%
Ginsenoside Ro					TXA₂ TXA₂/TP		99.81%
AZD1981	DP						99.37%
Seratrodast					TXA₂/TP		98.86%
Omidenepag isopropyl		EP2					99.20%
Pectolinarin		EP					99.89%
Nedocromil	PGD2						98.02%
Ebopiprant			Human FP Receptor, Ki: 1 nM Rat FP Receptor, Ki: 26 nM				98.65%
Beraprost sodium				IP			99.88%
NTP42					TXA₂		98.02%
BW 245C	DP						99.73%
MRE-269				IP Receptor IP			99.91%
Prostaglandin E2-d₄		EP					≥99.0%
CJ-42794		EP, EC₅₀: 10 nM					98.96%
Prostaglandin J2	hDP, Ki: 0.9 nM hCRTH2, Ki: 6.6 nM	hEP1, Ki: 15.678 μM hEP2, Ki: 989 nM hEP3, Ki: 319 nM hEP4, Ki: 1065 nM	hFP, Ki: 553 nM	hIP, Ki: >25 μM	hTP, Ki: 6426 nM		98.10%
L-902688		EP4, Ki: 0.38 nM EP4, EC₅₀: 0.6 nM					≥99.0%
Ozagrel					TXA₂		99.74%
Vidupiprant	DP						98.33%
MF-766		EP4, Ki: 0.23 nM					99.69%
Treprostinil sodium	DP1, EC₅₀: 0.6±0.1 nM DP1, Ki: 4.4 nM	EP1, EC₅₀: 285 nM EP1, Ki: 212 nM EP2, EC₅₀: 6.2±1.2 nM EP2, Ki: 3.6 nM EP3, EC₅₀: 68.9 nM EP3, Ki: 2505 nM EP4, EC₅₀: 181 nM EP4, Ki: 826 nM	FP Receptor, Ki: 4680 nM	IP Receptor, EC₅₀: 1.9 nM IP Receptor, Ki: 32.1 nM	TP Receptor, EC₅₀: 919 nM		99.78%
p-Hydroxycinnamic acid						TXB₂, IC₅₀: 371 μM	99.94%
EP2 receptor antagonist-2		EP					98.69%
(+)-Cloprostenol			PGF_2α				99.28%
MF498		EP4, Ki: 0.7 nM					99.26%
Dinoprost tromethamine salt			FP Receptor				≥98.0%
L 888607	DP, Ki: 0.8 nM		FP Receptor, Ki: 10018 nM	IP Receptor, Ki: 14434 nM	TP Receptor, Ki: 283 nM		99.87%
Licarin A	DP						98.48%
BAY 73-1449				IP Receptor, IC₅₀: <0.1 nM			99.99%
Evatanepag		EP2					99.78%
SC 51089 free base		EP1, Ki: 1.3 μM EP3, Ki: 17.5 μM	FP, Ki: 61.1 μM		TP, Ki: 11.2 μM		98.64%
Ralinepag	hDP1, EC₅₀: 850 nM			hIP, EC₅₀: 8.5 nM rIP, EC₅₀: 530 nM			99.79%
Sulprostone		EP3					≥99.0%
PDC31			FP Receptor, Ki: ~30 nM				99.76%
Carbacyclin				PGI₂ Receptor			≥98.0%
Latanoprost acid			FP				99.62%
EP3 antagonist 3		EP3, pKi: 8.3					99.57%
Ozagrel sodium					TXA₂		99.98%
Setipiprant	hCRTH2, IC₅₀: 6 nM hDP1, IC₅₀: 1290 nM	EP2, IC₅₀: 2600 nM					98.23%
Ozagrel hydrochloride					TXA₂		99.68%
Taprenepag isopropyl		EP2					99.23%
Darbufelone mesylate			PGF_2α				99.65%
Misoprostol acid		EP					≥99.0%
MK-7246	DP, Ki: 2.5 nM				TP, Ki: 3804 nM		99.63%
Epibetulinic acid		EP2, IC₅₀: 0.6 μM					≥98.0%
BAY-6672 hydrochloride			FP				98.44%
BI-671800	hCRTH2, IC₅₀: 4.5 nM mCRTH2, IC₅₀: 3.7 μM						99.36%
Prostaglandin E2 (Standard)		EP
CAY10580		EP4, Ki: 35 nM EP2, Ki: 3000 nM EP3, Ki: 2000 nM EP1, Ki: >3000 nM
Treprostinil palmitil	DP						99.62%
Pizuglanstat	DP						99.70%
BW A868C	DP2						99.00%
L 888607 Racemate	DP1, Ki: 132 nM				TP, Ki: 17 nM		99.83%
GSK-269984A		EP1, pIC₅₀: 7.9					99.74%
Carboprost tromethamine			FP				99.85%
Carboprost			FP				99.83%
Pexopiprant	DP2, Ki: <100 nM						99.30%
BAY-1316957		human EP4-R, IC₅₀: 15.3 nM					99.73%
Nedocromil sodium	DP
EP4-IN-1		EP4					99.94%
BGC-20-1531 free base		EP4, pKd: 7.6					98.05%
KP496					TXA₂ Receptor		99.79%
Tiaprost			PGF_2α				≥98.0%
Selexipag-d₇				IP
15-keto-Prostaglandin F2a			FP				99.2%
Aganepag		EP2, EC₅₀: 0.19 nM					99.71%
Tafluprost acid		EP3, IC₅₀: 67 nM	Human FP Receptor, Ki: 0.4 nM Human FP Receptor, EC₅₀: 0.53 nM				99.80%
Daltroban					TXA₂		98.1%
Rivenprost		EP4, Ki: 0.7 nM
Prostaglandin D2-d₉	DP						≥99.0%
CAY10471	CRTH2
Treprostinil diethanolamine	DP1, Ki: 4.4 nM	EP2, Ki: 3.6 nM EP1, Ki: 212 nM EP4, Ki: 826 nM EP3, Ki: 2505 nM	FP, Ki: 4680 nM	IP, Ki: 32.1 nM			99.44%
SC 51089		EP1, Ki: 1.3 μM EP3, Ki: 17.5 μM	FP, Ki: 61.1 μM		TP, Ki: 11.2 μM
Iloprost-d₄				IP
EP4 receptor agonist 2		EP4, EC₅₀: 0.8 nM EP2, Ki: >100000 nM EP3, Ki: 38000 nM EP4, Ki: 3.1 nM					≥99.0%
Sulotroban					TXA₂ Receptor
ONO-8711		EP
AMG-009	DP, IC₅₀: 3 nM						98.08%
BAY-6672			FP
EP4 receptor antagonist 2		EP4, IC₅₀: 7.8 nM
Laropiprant sodium	DP, Ki: 0.57 nM				TP, Ki: 2.95 nM
EP3 antagonist 6		EP3, IC₅₀: 1.9 nM
ASP7657 free base		hEP4, IC₅₀: 2.21 nM rat EP4, IC₅₀: 6.02 nM
CAY10535			FP Receptor		TP Receptor
Thromboxane A2					TP
Prostaglandin E2-d₉		EP
17-Phenyl-ω-trinor-PGE2		EP1 EP3
Prostaglandin E1-d₉		EP
Treprostinil-¹³C₂,d	DP	EP
GSK345931A		EP1
Ramatroban-d₄					TXA₂/TP
11-Deoxy-16,16-dimethyl-PGE2		EP2 EP3
TP-16		EP4, IC₅₀: 2.1 nM
KMN-80		EP4, Ki: 2.35 nM EP4, IC₅₀: 3 nM
I-SAP					TXA₂ Receptor
BM567					TXA₂ Receptor, IC₅₀: 1.1 nM TXA₂ synthase, IC₅₀: 12 nM
Prostaglandin F2α dimethyl amine			FP
EP4 receptor agonist 1		hEP4, pEC₅₀: 6.3
Travoprost (Standard)			FP
(R)-Vorbipiprant		hEP4, Ki: 16.6 nM
AMX12006		hEP4, IC₅₀: 4.3 nM
Prostaglandin D2-d₄	DP
EP2 receptor agonist 4		EP2, EC₅₀: 43 nM
Saikogenin D		EP					98.95%
8-iso-15-keto Prostaglandin F2α			FP
Latanoprost (Standard)			FP Receptor
Selexipag-d₆				IP
Etersalate					TXA₂
Misoprostol acid-d₅		EP
L-644698	hDP receptor, Ki: 0.9 nM	hEP2, Ki: 267 nM hEP3, Ki: 3730 nM hEP4, Ki: 9280 nM
ER-819762		EP4, IC₅₀: 70 nM
Cloprostenol isopropyl ester			FP
Nocloprost		EP1 EP3
BGC-20-1531		EP4
Prostaglandin A3		EP2, IC₅₀: 120 nM EP4, IC₅₀: 20 nM
PGN-9856		EP2, pEC₅₀: ≥ 8.5 EP2, pKi: ≥ 8.3					98.90%
LCB-2853					TXA₂ Receptor
AZ-1355				Prostaglandin I₂	TXA₂/TP		98.19%
RS-601					TXA₂ Receptor
MK-8318	DP, Ki: 5.0 nM
MK-447				PGI₂
CAY10595	DP, Ki: 10 nM
2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide				PGI₂
AGN 210676	hDP receptor, EC₅₀: 7749 nM	EP2, EC₅₀: 5 nM hEP3, EC₅₀: 153 nM
CI-949						TXB₂, IC₅₀: 0.1 μM
YM158 free base					TXA₂ Receptor, pA2: 8.81
Bunaprolast						TXB₂
KF 13218						TXB₂, IC₅₀: 5.3 nM

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4